Access to Tyrosine Kinase Inhibitors and Survival in Patients with Advanced EGFR+ and ALK+ Positive Non–small-cell Lung Cancer Treated in the Real-World
| Autor: | Goulart, Bernardo H.L., Chennupati, Shasank, Fedorenko, Catherine R., Ramsey, Scott D. |
|---|---|
| Zdroj: | In Clinical Lung Cancer September 2021 22(5):e723-e733 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect